Drugs for HER-2-positive breast cancer

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Sibilia, Maria., Zielinski, Christoph C., Bartsch, Rupert., Grunt, Thomas W.
Format: Livro
Jezik:Inglês
Izdano: Springer, 2011
Serija:Milestones in Drug Therapy,
Teme:
Farmacologia.
Oncologia.
Câncer Pesquisa.
Anticorpos.
Imunologia.
Medicina interna.
Online dostop:https://minerva.ufrj.br/F/?func=direct&doc_number=000895504&local_base=UFR01
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki